Search results

This indicator covers the percentage of adults and young people at a GP surgery in an area of high or extremely high HIV prevalence who have not had an HIV test in the last 12 months, who are having a blood test and receive an HIV test at the same time. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM190

Result type

General practice indicators suitable for use outside of QOF

Published

31 July 2019

This indicator covers the percentage of adults and young people newly registered with a GP in an area of high or extremely high HIV prevalence who receive an HIV test within 3 months of registration. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM189

Result type

General practice indicators suitable for use outside of QOF

Published

1 August 2019

Evidence-based recommendations on roxadustat (Evrenzo) for treating symptomatic anaemia associated with chronic kidney disease in adults.

Result type

Technology appraisal guidance

Published

13 July 2022

GPs help to bring a primary care perspective to the guidance that we produce.

GPs help to bring a primary care perspective to the guidance that we produce.

Evidence-based recommendations on canagliflozin (Invokana) in combination therapy for treating type 2 diabetes in adults.

Result type

Technology appraisal guidance

Published

25 June 2014

Evidence-based recommendations on low dose rate brachytherapy for localised prostate cancer. This involves placing small radioactive seeds into the prostate that give off low doses of radiation to destroy cancer cells.

Result type

HealthTech guidance

Published

27 July 2005

This indicator covers the percentage of people aged 45 to 84 years who have a recorded cardiovascular disease (CVD) risk assessment score in the preceding 5 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes

Result type

Network / system level indicators

Published

15 August 2024

Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.

NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.

Summaries of the best available evidence for selected medicines that are considered to be of significance to the NHS.

Home Implementing NICE guidance...

Our HealthTech Programme considers technologies that could offer benefits to patients and the health and social care system over current practice.

Evidence-based recommendations on tests in secondary care to identify people at high risk of ovarian cancer. The tests are the IOTA ADNEX model, Overa (MIA2G), RMI I (at thresholds other than 250), ROMA and IOTA Simple Rules.

Result type

HealthTech guidance

Published

15 November 2017

Virtual wards (also known as hospital at home) provide hospital level care at home.